In this episode of Avalere Health Essential Voice, our experts discuss what they expect to see from a legislative perspective this fall on Capitol Hill.

In this episode of Avalere Health Essential Voice, our experts discuss the forthcoming debate around the coverage gap for individuals residing in states that have not participated in Medicaid expansion.

In this episode of Avalere Health Essential Voice, our experts welcome leaders from Jazz Pharmaceuticals and Coherus BioSciences to discuss the use of third-party logistics companies for distribution, warehousing, and fulfillment in biopharma.

In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss value-based payment arrangements in cell and gene therapies and the role they play in facilitating access to these products.

In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss Huntington’s Disease through the lens of its symptoms, challenges, and potential treatment.

In this episode of Start Your Day with Avalere, Chris Johnson of Landmark Health joins us to discuss his organization’s experience as an early participant in CMMI’s Direct Contracting payment model.

In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss the challenges surrounding cell and gene therapies from both the patient and payer perspective.

In this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a study on the impact of Medicaid expansion on coverage and care for women of reproductive age.

In this episode of Avalere Health Essential Voice in our Start Your Day with Avalere series, our experts return for the final session in our 3-part series on infusing the patient perspective into value assessment. 

In this episode of the Avalere Health Essential Voice Disease Education Series, experts from Community Oncology Alliance (COA) and Texas Oncology join us to discuss the state of oncology care from a provider and a patient perspective as we continue to look at the impact of COVID-19 and prepare for post-pandemic realities.